Suppression of ADAM8 attenuates angiotensin II-induced cardiac fibrosis and endothelial-mesenchymal transition via inhibiting TGF-β1/Smad2/Smad3 pathways.
Sign Up to like & getrecommendations! Published in 2021 at "Experimental animals"
DOI: 10.1538/expanim.21-0064
Abstract: Endothelial-to-mesenchymal transition (EndMT) is involved in cardiac fibrosis induced by angiotensin II (Ang II). A disintegrin and metalloproteinase 8 (ADAM8), a member of ADAMs family, participates in cell adhesion, proteolysis and various signaling. However, its… read more here.
Keywords: tgf smad2; induced cardiac; fibrosis; cardiac fibrosis ... See more keywords